
Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests
This collection summarizes ADHD as it relates to bipolar disorder and borderline personality disorders; culturally competent care for the African-American population; issues with sleep disorders; and more.